Initiated Expansion Stage of Phase 2 Clinical Trial for Novel Treatment for Acute Myeloid Leukemia

BioLineRx Initiated Expansion Stage of Phase 2 Clinical Trial for Novel Treatment for Acute Myeloid Leukemia. BL-8040 remains safe and well tolerated at highest dose; continues to induce robust mobilization and leukemia cell death